JBCHEPHARM

JB Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM

BSE: 506943

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

2,344.80+23.6 (+1.02%)

3 Jul, 9:59 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

96.5 / 100

Value Score

19.5 / 100

Price Momentum Score

92.8 / 100

QVM Score

88.0 / 100

Key Metrics

Market Cap

37269.00

P/E (TTM)

52.53

P/B

8.96

P/S (TTM)

8.99

EV/EBITDA

32.52

CAPE (5Y)

67.22

ROE (TTM)

18.69

ROCE (TTM)

24.26

ROA (TTM)

15.35

Avg 3Y ROE

19.97

Earnings 3Y CAGR

19.95

Sales 3Y CAGR

9.61

Sales 5Y CAGR

15.22

Debt/Equity

0.00

Consensus TP

2124.50

Strong Buy %

57.14

Promoter Holding

48.80

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of JB Chemicals & Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 92.8 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

92.8 / 100

Analysts have been raising forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has increased by 0.4% in the last 3 months, indicating earnings momentum

What is Earnings upgrade (3M)?

High and stable operating margin

The company reported strong operating margin of 22.3% for 12-month ended 31 Mar 2026 and operating margin improved marginally by 33 bps from 1 year ago

What is Operating profit margin?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.0 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 52.53 indicates that the stock is expensive on a standalone basis and is at a 73.6% premium to industry median P/E

What is P/E Ratio?

Median: 30.26

Value 52.53

-215.443183

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 5.87% for 12-month ended 31 Mar 2026 and the growth was 5.37 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 5.87

-82.35114662

Low EPS growth and in line with median growth of industry

The company delivered low EPS growth of 8.65% for 12-month ended 31 Mar 2026 and the growth was 0.53 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.85%

What is Dividend yield?

Neutral

High ROE but declining trend

The company reported strong ROE of 18.69% for 12-month ended 31 Mar 2026 but ROE declined by -205 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 59.1 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

59.1 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for JB Chemicals & Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

JB Chemicals & Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of JB Chemicals & Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	55.91	55.91	55.91	55.91	55.91	55.91	55.91	54.00	54.00	54.00	53.96	53.95	53.93	53.91	53.86	53.83	53.78	53.77	53.74	53.66	47.84	47.73	47.56	47.55	48.80
Indian Promoter	55.91	55.91	45.91	1.91	1.91	1.91	1.91	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	48.80
Foreign Promoter	-	-	10.00	54.00	54.00	54.00	54.00	54.00	54.00	54.00	53.96	53.95	53.93	53.91	53.86	53.83	53.78	53.77	53.74	53.66	47.84	47.73	47.56	47.55	-
Institutions	21.74	22.13	19.63	21.78	20.71	21.50	23.97	25.38	26.11	26.65	27.13	27.35	27.71	28.19	28.63	28.88	29.44	29.79	30.45	31.04	37.02	37.40	38.13	38.23	37.71
Mutual Funds / UTI	13.17	12.23	10.60	12.06	10.56	10.55	12.80	13.75	14.27	15.12	15.40	15.62	16.17	15.57	15.57	15.66	15.45	15.04	14.60	14.57	16.26	16.27	19.15	19.61	19.00
FI/Bank/Insurance	0.23	0.95	1.04	1.17	1.84	1.77	1.96	2.28	2.39	2.40	2.67	2.41	2.39	2.55	2.45	2.30	2.36	1.93	1.62	1.25	1.77	2.68	2.21	2.16	1.33
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	-	-	-
FII	7.18	7.78	7.25	7.87	7.54	8.37	8.74	9.12	9.22	8.85	8.66	8.81	8.62	9.53	10.05	10.35	11.06	12.17	13.63	14.65	18.30	17.77	15.31	14.88	16.33
Other Institutions	1.15	1.17	0.74	0.68	0.76	0.81	0.48	0.22	0.23	0.28	0.40	0.52	0.52	0.53	0.56	0.57	0.57	0.64	0.58	0.58	0.68	0.67	1.47	1.58	1.05
Non-Institution	22.35	21.96	24.47	22.31	23.38	22.58	20.12	20.62	19.89	19.35	18.91	18.71	18.36	17.91	17.51	17.28	16.78	16.43	15.82	15.29	15.14	14.88	14.30	14.22	13.48
Bodies Corporate	0.96	1.08	1.83	0.96	1.18	1.16	0.88	0.75	0.70	0.68	0.68	0.69	0.66	0.59	0.57	0.54	0.54	0.54	0.53	0.51	0.50	0.42	0.68	0.66	0.56
Others (incl. Retail) No. of shareholders	21.39 34,523	20.88 40,156	22.64 60,973	21.35 57,795	22.20 64,976	21.42 69,968	19.24 70,991	19.87 64,198	19.19 60,680	18.67 59,674	18.23 58,003	18.02 59,160	17.70 56,027	17.32 55,348	16.94 60,139	16.74 62,531	16.24 63,175	15.89 66,239	15.29 62,060	14.78 61,405	14.64 63,240	14.46 69,334	13.62 71,281	13.56 68,697	12.92 73,370

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Smallcap250 Quality 50	3.11%	6 / 50
2	Nifty Pharma	2%	16 / 20
3	Nifty Smallcap 250	0.89%	18 / 249
4	Nifty 500	0.09%	204 / 499
5	Nifty Total Market	0.09%	207 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in JB Chemicals & Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Sujay Kamlakar Rajhans Designated Person	March-2026	Market Sale (Disposal) 19th Mar 2026	0.01 %	₹ 2,110.00	11.81 k	₹ 2.49 cr
Torrent Pharmaceuticals Limited Promoter	February-2026	Off Market (Acquisition) 4th Feb 2026	48.75 %	₹ 1,600.00	92.49 k	₹ 14.80 cr
Stewart Graham Barker Designated Person	February-2026	Off Market (Disposal) 4th Feb 2026	0.06 %	₹ 1,600.00	92.49 k	₹ 14.80 cr
Satya Prakash Thakur Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.01 %	₹ 1,600.00	14.53 k	₹ 2.32 cr
Nitesh Kumar Pandey Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.02 %	₹ 1,600.00	26.30 k	₹ 4.21 cr
Omprakash Ramji Verma Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.01 %	₹ 1,600.00	9.89 k	₹ 1.58 cr
Parasram Balaji Borge Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.00 %	₹ 1,600.00	6.80 k	₹ 1.09 cr
Parmeshwar Bhawarlalji Bang Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.04 %	₹ 1,600.00	62.32 k	₹ 9.97 cr
Patel Sanjay Chandubhai Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.01 %	₹ 1,600.00	8.79 k	₹ 1.41 cr
Pradeep Kumar Singh Designated Person	January-2026	Off Market (Disposal) 27th Jan 2026	0.11 %	₹ 1,600.00	1.73 lac	₹ 27.75 cr

…

Corporate Actions

History of JB Chemicals & Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 9.30/share
Record date: 29th May 2026Ex-date: 29th May 2026
Announced on: 11th May 2026
Dividend₹ 12.70/share
Record date: 11th Feb 2026Ex-date: 11th Feb 2026
Announced on: 5th Feb 2026
Dividend₹ 7/share
Record date: 30th Jul 2025Ex-date: 30th Jul 2025
Announced on: 14th May 2025
Dividend₹ 8.50/share
Record date: 8th Feb 2025Ex-date: 7th Feb 2025
Announced on: 4th Feb 2025
Dividend₹ 6.75/share
Record date: 14th Aug 2024Ex-date: 14th Aug 2024
Announced on: 17th May 2024

Company Profile

Overview of JB Chemicals & Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). T...

Key personnel

Mr. Kaushal Singh Solanki

Chief Financial Officer

Mr. Sandeep Anil Phadnis

Company Secretary, Compliance Officer, Vice President - Secretarial

Mr. Arun DuggalD

Non-Executive Independent Chairman of the Board

Mr. Aman Samir MehtaD

Managing Director, Executive Director

Mr. Amal Satyawan KelshikarD

Non-Executive Non-Independent Director

Mr. Sudhir MenonD

Non-Executive Non-Independent Director

Mr. Hasmukh Mathurbhai PatelD

Non-Executive Non-Independent Director

Ms. Richa AroraD

Non-Executive Independent Director

View all

Incorporated on

18 Dec 1976

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

5,602

IPO date

02 Feb 1995

Free Float

8,15,24,267

Website

https://jbpharma.com/

Phone no.

+912224395200

Address

NEELAM CENTRE, 4TH FLOOR, B WING, HIND CYCLE ROAD,, WORLI, , 400030, India

Frequently Asked Questions

What is the current share price of JB Chemicals & Pharmaceuticals Ltd.?

The current share price of JB Chemicals & Pharmaceuticals Ltd. is ₹ 2,344.80 as of 3 Jul 2026.

What is the market capitalisation of JB Chemicals & Pharmaceuticals Ltd.?

The market capitalisation of JB Chemicals & Pharmaceuticals Ltd. stands at ₹ 37,269.00 Cr.

What is the PE ratio of JB Chemicals & Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of JB Chemicals & Pharmaceuticals Ltd. is 52.53 as of the latest trailing twelve months data.

What is the ROE and ROCE of JB Chemicals & Pharmaceuticals Ltd.?

JB Chemicals & Pharmaceuticals Ltd. has a Return on Equity (ROE) of 18.69% and a Return on Capital Employed (ROCE) of 24.26% as per the latest financial reports.

What is the 52-week high and low of JB Chemicals & Pharmaceuticals Ltd.?

The 52-week high of JB Chemicals & Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of JB Chemicals & Pharmaceuticals Ltd.?

The dividend yield of JB Chemicals & Pharmaceuticals Ltd. is 0.85% based on the current market price.

What is the FII and DII holding in JB Chemicals & Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 16.33%, Domestic Institutional Investors (DII) hold 20.33% and retail/public investors hold 12.92% of JB Chemicals & Pharmaceuticals Ltd. shares.

What sector does JB Chemicals & Pharmaceuticals Ltd. belong to?

JB Chemicals & Pharmaceuticals Ltd. operates in the Healthcare sector. 57.14% of analysts have a Buy or Strong Buy rating on JB Chemicals & Pharmaceuticals Ltd. with a consensus target price of ₹ 2,124.50, implying 8.47% downside from current levels.

What is the beta of JB Chemicals & Pharmaceuticals Ltd.?

The beta of JB Chemicals & Pharmaceuticals Ltd. is 0.33, indicating its price volatility relative to the broader market. Over the past 1 year, JB Chemicals & Pharmaceuticals Ltd. has delivered an absolute return of 28.98%.

What is the RSI of JB Chemicals & Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of JB Chemicals & Pharmaceuticals Ltd. is 70.29, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

JB Chemicals & Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

JB Chemicals & Pharmaceuticals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile

Corporate Actions